-
2013
Company Description
SutroVax is a biopharmaceutical company
SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines. SutroVax is an independent company that was spun out of Sutro Biopharma with an exclusive license to Sutro Biopharma’s Xpress CF platforms for cell free protein synthesis and site-specific conjugation.
-
Manufacturer:
Science and Engineering -
Formed:
2013 -
Founders:
Grant E. Pickering -
Company Website:
-
Company E-mail:
-
Company Address:
400 E Jamie Court, Suite 205South San Francisco, CAUnited States -
CEO:
- Grant E. Pickering
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits